Predictive Potentials of ZEB1-AS1 in Colorectal Cancer Prognosis and Their Correlation with Immunotherapy

Figure 5

Building and validating a predictive nomogram. (a) A nomogram for predicting overall survival (OS) in colorectal cancer patients at 1, 3, and 5 years. (b) Nomogram calibration curves for OS prediction at 1, 3, and 5 years. (c) ROC analysis with the TCGA training cohort. (d) ROC analysis with the TCGA testing cohort.

(a)

(b)

(c)

(d)